Lung Cancer
Volume 45 , Pages S1-S2 , August 2004

Second Heidelberg Thoracic Oncology Symposium on the Diagnosis and Treatment of Pleural Mesothelioma–introduction

  • Nicholas Thatcher

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-161-446-3749/3745/3848; fax: +44-161-446-3299/8000.

References 

  1. Scagliotti GV, Shin DM, Kindler HL. Phase III study of pemetrexed with and without folic acid and vitamin B12 as front line therapy in malignant pleural mesothelioma. J. Clin Oncol. 2003;97:2056–2063
  2. Vogelzang NJ, Rustoven JJ, Symanowski J. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin Oncol. 2003;21:2629–2630
  3. Girling JD, Muers MF, Quian W, Lobban D. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council. Semin. Oncol. 2002;29:97–101

PII: S0169-5002(04)00161-8

doi: 10.1016/j.lungcan.2004.04.003

Lung Cancer
Volume 45 , Pages S1-S2 , August 2004

Article Tools